Stoke Therapeutics, Inc. (STOK) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Stoke Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.276 Hello, and thank you for standing by. My name is Bella, and I will be your conference 00:00:04.276 -- 00:00:09.521 operator today. At this time, I would like to welcome everyone to SOAP Therapeutics' 00:00:09.521 -- 00:00:14.006 first quarter 2026 business and financial update conference call. 00:00:14.006 -- 00:00:17.550 All lines have been placed on mute to prevent any background noise. 00:00:17.550 -- 00:00:22.195 After the speaker's remarks, there will be a question and answer session. 00:00:22.195 -- 00:00:27.605 We do request for today's session that you please limit to two questions only. 00:00:27.605 -- 00:00:32.430 If you would like to ask a question during this time, simply press star, then the number 00:00:32.430 -- 00:00:36.494 one or telephone keypad. To withdraw your question, press star one again. 00:00:36.494 -- 00:00:40.457 I would now like to turn the conference over to Thomas Leggett. 00:00:40.457 -- 00:00:42.519 Chief Financial Officer, you may begin. 00:00:42.519 -- 00:00:44.121 Good 00:00:44.121 -- 00:00:48.225 afternoon and welcome to Stoke Therapeutics' first quarter 2026 Business Update conference 00:00:48.225 -- 00:00:52.549 call. I'm Thomas Leggett, Chief Financial Officer of Stoke Therapeutics. 00:00:52.549 -- 00:00:57.721 Joining me on today's call are Ian Smith, our Chief Executive Officer, Dr. 00:00:57.721 -- 00:01:03.286 Barry Tico, Chief Medical Officer, and Jason Hoyt, Chief Patient Officer. 00:01:03.449 -- 00:01:06.553 As a reminder, today's webcast presentation is available in the Investors section of 00:01:06.553 -- 00:01:10.219 our website. This webcast is being recorded and will be available for replay later this 00:01:10.219 -- 00:01:11.621 evening. 00:01:11.621 -- 00:01:15.146 Before we begi...